pentoxifylline has been researched along with Arterial Occlusive Diseases in 114 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 9.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 9.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "Vascular impotence is a common medical problem for which available therapies are limited." | 5.28 | Pentoxifylline in the treatment of vascular impotence--case reports. ( Allenby, KS; Burris, JF; Mroczek, WJ, 1991) |
| "To evaluate the use of pentoxifylline to treat impotence in men with mild to moderate penile vascular insufficiency." | 5.07 | Treatment of vasculogenic sexual dysfunction with pentoxifylline. ( Korenman, SG; Viosca, SP, 1993) |
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 5.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 5.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "Pentoxifylline was significantly more effective than the placebo in increasing both the initial and absolute claudication distance (ICD and ACD) in patients with peripheral chronic occlusive arterial disease (COAD)." | 3.76 | Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. ( Aggarwal, KK; Chopra, HK; Chopra, KL; Parashar, SK, 1988) |
| "To examine the effect of pentoxifylline (PTX) on cytokine levels, lipid peroxidation, and antioxidant enzymes in a rabbit model of spinal cord ischemia-reperfusion injury induced by aortic occlusion." | 3.71 | Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits. ( Cindaş, A; Delibaş, N; Savaş, C; Savaş, S; Sütçü, R, 2002) |
| " infusion of pentoxifylline, administering 1,200 mg/24 hours through 15 days, was studied in 22 patients (19 m, 3 f) with arteriographically confirmed extensive occlusion in the femoro-popliteal segment, associated with marked intermittent claudication and rest pain of varying severity." | 3.67 | Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease. ( Angelides, NS, 1986) |
| "In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months." | 3.66 | [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. ( Brock, FE; Nobbe, F; Rudofsky, G; Ulrich, M, 1979) |
| "Intermittent claudication is the primary symptom of chronic obstructive arteriopathies of the lower extremities." | 2.70 | Therapeutic effects of Vascupump treatment patients with Fontaine Stage II B arteriopathy. ( Allegra, C; Bartolo, M; Martocchia, R, 2001) |
| "Pentoxifylline (PTX) has a well-demonstrated ability to act on the activated neutrophils." | 2.68 | Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion. ( Aillaud, MF; Alimi, Y; Bienvenu, J; Fabre, D; Fossat, C; Juhan, C; Juhan-Vague, I; Lenoble, M, 1995) |
| " Compliance with treatment and occurrence of adverse events were constantly monitored; systemic tolerability was evaluated through the use of routine haematological and haematochemical tests." | 2.68 | Controlled clinical trial on the efficacy and safety of oral sulodexide in patients with peripheral occlusive arterial disease. ( Shustov, SB, 1997) |
| "Pentoxifylline was not more effective (+105%) whereas PGE1 showed a remarkable increase (+605%)." | 2.67 | [Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training]. ( de la Hamette, D; Müller, H; Scheffler, P, 1991) |
| "Pentoxifylline was found both in healthy subjects and patients to significantly increase prostacyclin plasma concentration after i." | 2.66 | Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. ( Boddi, M; Masotti, G; Poggesi, L; Scarti, L; Serneri, GG, 1985) |
| " Treatment lasted 7 to 8 weeks with a dosage of 1 tablet 3 times a day." | 2.64 | [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)]. ( Kellner, H, 1976) |
| "Pentoxifylline (PTX) is a methylxanthine derivative whose diverse mechanisms of action are now extensively documented." | 2.39 | Prevention studies with pentoxifylline: new clinical projects. ( Eugène-Jolchine, I; Milpied, N, 1995) |
| "Pentoxifylline was first registered (in Germany) 20 years ago." | 1.28 | [20 years pentoxifylline: a part of recent angiology history]. ( Ernst, E, 1992) |
| "Vascular impotence is a common medical problem for which available therapies are limited." | 1.28 | Pentoxifylline in the treatment of vascular impotence--case reports. ( Allenby, KS; Burris, JF; Mroczek, WJ, 1991) |
| "Pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities (clinical Fontaine Stages III and IV) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy." | 1.27 | Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. ( Seige, K; Sternitzky, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 78 (68.42) | 18.7374 |
| 1990's | 23 (20.18) | 18.2507 |
| 2000's | 11 (9.65) | 29.6817 |
| 2010's | 2 (1.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melzer, J | 1 |
| Saller, R | 1 |
| Pua, U | 1 |
| Anand, S | 3 |
| Creager, M | 3 |
| Koshkin, VM | 3 |
| Tulsyan, N | 1 |
| Ouriel, K | 1 |
| Kashyap, VS | 1 |
| Regensteiner, JG | 2 |
| Stewart, KJ | 1 |
| Il'in, VN | 1 |
| Stepanov, NV | 1 |
| Ikhaev, ZA | 1 |
| Sharonin, GV | 1 |
| Bogdanets, LI | 2 |
| Heidrich, H | 3 |
| Ambrus, CM | 2 |
| Ambrus, JL | 2 |
| Gastpar, H | 2 |
| Sharma, SD | 1 |
| Suh, OW | 1 |
| Moore, RH | 2 |
| Williams, P | 1 |
| Atroshchenko, ES | 1 |
| Maughan, RJ | 2 |
| Broom, J | 1 |
| Smith, G | 1 |
| Leiper, JB | 1 |
| Ah-See, AK | 1 |
| Engeset, J | 1 |
| Evan-Wong, A | 1 |
| Davidson, RJ | 1 |
| Taheri, SA | 1 |
| Reddington, MM | 1 |
| Taheri, P | 1 |
| Kahn, EA | 1 |
| Schattman, GL | 1 |
| Dean, LS | 1 |
| Di Perri, T | 1 |
| Carandente, O | 1 |
| Vittoria, A | 1 |
| Guerrini, M | 2 |
| Messa, GL | 1 |
| Grandillo, F | 1 |
| Giunta, R | 1 |
| Scognamiglio, G | 1 |
| Tirelli, A | 1 |
| Coppola, L | 1 |
| Torella, R | 1 |
| Benignetti, G | 1 |
| Fabbri, F | 1 |
| Benvenuti, C | 1 |
| Angelkort, B | 8 |
| Kiesewetter, H | 4 |
| Trübestein, G | 3 |
| Trübestein, R | 1 |
| Duong, QD | 1 |
| Accetto, B | 1 |
| Porter, JM | 1 |
| Cutler, BS | 1 |
| Lee, BY | 2 |
| Reich, T | 1 |
| Reichle, FA | 2 |
| Scogin, JT | 1 |
| Strandness, DE | 1 |
| Dauer, U | 1 |
| Mussler, K | 1 |
| Teitel, P | 1 |
| Seiffge, D | 1 |
| Schmid-Schönbein, H | 1 |
| Chmiel, H | 1 |
| Anadere, I | 1 |
| Heimburg, P | 1 |
| Pecchi, S | 1 |
| Rossi, C | 1 |
| Cappelli, R | 1 |
| Pieragalli, D | 1 |
| Acciavatti, A | 1 |
| Perego, MA | 2 |
| Sergio, G | 2 |
| Artale, F | 2 |
| Pupita, F | 1 |
| Rotatori, P | 1 |
| Frausini, G | 1 |
| Küchle, HJ | 3 |
| Richard, G | 2 |
| Feruglio, FS | 1 |
| Ponte, E | 1 |
| Zaccaria, A | 1 |
| Antonini, M | 1 |
| Marciani, A | 1 |
| Taurino, M | 1 |
| Speziale, F | 1 |
| Spartera, C | 1 |
| Gnauen, H | 1 |
| Schoop, W | 1 |
| Boateng, K | 2 |
| Maurin, N | 2 |
| Tannenberg, G | 1 |
| Makarova, NP | 1 |
| Ermolaev, VL | 1 |
| Zavalskiĭ, II | 1 |
| Marci, M | 1 |
| Albiani, B | 1 |
| Ricci, M | 1 |
| Russo, F | 1 |
| Ciuffetti, G | 1 |
| Paltriccia, R | 1 |
| Lombardini, R | 1 |
| Lupattelli, G | 1 |
| Pasqualini, L | 1 |
| Mannarino, E | 1 |
| Scheffler, P | 3 |
| de la Hamette, D | 2 |
| Gross, J | 1 |
| Mueller, H | 1 |
| Schieffer, H | 1 |
| Isner, JM | 1 |
| Rosenfield, K | 1 |
| Hiatt, WR | 1 |
| Korenman, SG | 1 |
| Viosca, SP | 1 |
| Makarova, LD | 1 |
| Eugène-Jolchine, I | 1 |
| Milpied, N | 1 |
| Fossat, C | 1 |
| Fabre, D | 1 |
| Alimi, Y | 1 |
| Bienvenu, J | 1 |
| Aillaud, MF | 1 |
| Lenoble, M | 1 |
| Juhan-Vague, I | 1 |
| Juhan, C | 1 |
| Goodfield, M | 1 |
| Shustov, SB | 1 |
| McNamara, DB | 1 |
| Champion, HC | 1 |
| Kadowitz, PJ | 1 |
| Neels, K | 1 |
| Finkelstein, S | 1 |
| Douglass, C | 1 |
| Carman, TL | 1 |
| Fernandez, BB | 1 |
| Poliantsev, AA | 1 |
| Spasov, AA | 1 |
| Mozgovoĭ, PV | 1 |
| Karpenko, AV | 1 |
| Shcherbakov, VN | 1 |
| Kuznetsov, VI | 1 |
| Khomutnikova, AI | 1 |
| Kirichenko, OM | 1 |
| Allegra, C | 1 |
| Bartolo, M | 1 |
| Martocchia, R | 1 |
| Savaş, S | 1 |
| Delibaş, N | 1 |
| Savaş, C | 1 |
| Sütçü, R | 1 |
| Cindaş, A | 1 |
| Ehrly, AM | 4 |
| Tonak, J | 1 |
| Knecht, H | 1 |
| Groitl, H | 1 |
| Zicot, M | 1 |
| Müller, R | 2 |
| Nobbe, F | 2 |
| Schirop, T | 1 |
| Fichte, K | 1 |
| von Westphalen, JG | 1 |
| Sondern, W | 1 |
| Leube, G | 1 |
| Adil'khanov, SG | 1 |
| Antonova, NIu | 1 |
| Rudofsky, G | 4 |
| Brock, FE | 1 |
| Ulrich, M | 1 |
| Störmer, B | 2 |
| Kleinschmidt, F | 1 |
| Loose, D | 2 |
| Kremer, K | 2 |
| Doppelfeld, E | 1 |
| Völker, D | 1 |
| Mund-Hoym, WD | 1 |
| Kellner, H | 1 |
| Lehrach, F | 1 |
| Theis, H | 1 |
| Kleinschmidt, K | 1 |
| Ernst, E | 1 |
| Triebe, G | 1 |
| Münnich, U | 1 |
| Liebold, F | 1 |
| Stergachis, A | 1 |
| Sheingold, S | 1 |
| Luce, BR | 1 |
| Psaty, BM | 1 |
| Revicki, DA | 1 |
| Hepp, W | 1 |
| von Bary, S | 2 |
| Corovic, D | 1 |
| Diehm, C | 2 |
| Mühe, E | 1 |
| Vogelpohl, M | 1 |
| Müller, H | 1 |
| Verhaeghe, R | 1 |
| Verstraete, M | 1 |
| Allenby, KS | 1 |
| Burris, JF | 1 |
| Mroczek, WJ | 1 |
| Giansante, C | 1 |
| Di Chiara, A | 1 |
| Fiotti, N | 1 |
| Mauri, F | 1 |
| Sorrentino, A | 1 |
| Spanghero, M | 1 |
| Tomasin, L | 1 |
| Calabrese, S | 1 |
| Smith, MA | 1 |
| Fish, RC | 1 |
| Kostiunin, VN | 1 |
| Pakhomov, VI | 1 |
| Feoktistov, PL | 1 |
| Petrova, EA | 1 |
| Schweiger, H | 1 |
| Ortmeier, CJ | 1 |
| Haussler, KF | 2 |
| Künkel, HP | 2 |
| Schneider-May, H | 2 |
| Spengel, F | 2 |
| Symann, O | 2 |
| Werner, HJ | 2 |
| Crowder, JE | 1 |
| Cohn, JB | 1 |
| Savitsky, JP | 2 |
| Morgan, DL | 1 |
| Slywka, J | 1 |
| Cobert, BL | 1 |
| Hryniewicki, SW | 1 |
| Piccirillo, RT | 1 |
| Wilcox, CS | 1 |
| Galvin, KT | 1 |
| Gorst, KL | 1 |
| Primrose, JN | 1 |
| Kester, RC | 1 |
| Lindgärde, F | 1 |
| Jelnes, R | 1 |
| Björkman, H | 1 |
| Adielsson, G | 1 |
| Kjellström, T | 1 |
| Palmquist, I | 1 |
| Stavenow, L | 1 |
| Breddin, K | 1 |
| Gruss, JD | 1 |
| Heinrich, H | 1 |
| Horsch, S | 1 |
| Kriessmann, A | 1 |
| Maass, U | 1 |
| Martin, M | 1 |
| Hallett, JW | 1 |
| Manrique, RV | 1 |
| Manrique, V | 1 |
| Chopra, HK | 1 |
| Chopra, KL | 1 |
| Aggarwal, KK | 1 |
| Parashar, SK | 1 |
| Rössner, M | 1 |
| Blume, J | 2 |
| Jung, F | 2 |
| Gerhards, M | 2 |
| Leipnitz, G | 2 |
| Grossmann, K | 1 |
| Knischka, A | 1 |
| Turowski, A | 1 |
| Schmidt, HH | 1 |
| Sternitzky, R | 2 |
| Gleeson, M | 1 |
| Saeger-Lorenz, K | 1 |
| Loyd, RG | 1 |
| Prian, GW | 1 |
| Gomez, H | 1 |
| Laub, J | 1 |
| Mertz, GH | 1 |
| Runge, E | 1 |
| Thiele, P | 1 |
| Giunti, P | 1 |
| Danese, C | 1 |
| Angelides, NS | 1 |
| Naide, D | 1 |
| David, JS | 1 |
| Reichle, RM | 1 |
| Spürk, P | 1 |
| Habbaba, A | 1 |
| Mähder, M | 1 |
| Poggesi, L | 1 |
| Scarti, L | 1 |
| Boddi, M | 1 |
| Masotti, G | 1 |
| Serneri, GG | 1 |
| Berkowitz, P | 1 |
| May, GS | 1 |
| Brobst, J | 1 |
| McCann, WJ | 1 |
| Seige, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The THOR IDE Study[NCT05916950] | 155 participants (Anticipated) | Interventional | 2023-08-31 | Not yet recruiting | |||
| Multicenter, Randomized, Dose-search, Parallel, Double-blind, and Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Intramuscular Administration of Allogeneic Adipose Tissue Adult Mesenchymal Stem Cells in Diabetic Patients With Cri[NCT04466007] | Phase 2 | 90 participants (Anticipated) | Interventional | 2021-01-11 | Active, not recruiting | ||
| Predicting Peripheral Arterial Disease in Men With Erectile Dysfunction[NCT00743613] | 175 participants (Actual) | Observational | 2005-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for pentoxifylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Clinical studies in peripheral arterial occlusive disease: update from the aspects of a meta-narrative review].
Topics: Arterial Occlusive Diseases; Cilostazol; Complementary Therapies; Humans; Intermittent Claudication; | 2013 |
Peripheral arterial disease.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Cilostazol; Combin | 2002 |
Peripheral arterial disease.
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Cilostazol; Combin | 2002 |
[The use of pentoxyphylline in the treatment of patients with chronic obliterative diseases of lower limb arteries].
Topics: Administration, Oral; Arterial Occlusive Diseases; Blood Cells; Chronic Disease; Controlled Clinical | 2005 |
Emerging drugs in peripheral arterial disease.
Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Arteries; Aspirin; Clopidogrel; D | 2006 |
Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
Topics: Ankle; Arterial Occlusive Diseases; Blood Pressure; Brachial Artery; Cilostazol; Exercise Test; Exer | 2006 |
[Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy].
Topics: Ancrod; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiomyopathies; Dextrans; Digitalis | 1981 |
[Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Drug Therapy, Combination; Fe | 1995 |
Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Laser-Assisted; Angioplasty, Laser; Arterial Occlusive D | 1993 |
Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Laser-Assisted; Angioplasty, Laser; Arterial Occlusive D | 1993 |
Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Laser-Assisted; Angioplasty, Laser; Arterial Occlusive D | 1993 |
Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization.
Topics: Angioplasty, Balloon; Angioplasty, Balloon, Laser-Assisted; Angioplasty, Laser; Arterial Occlusive D | 1993 |
Nonsurgical management of peripheral arterial disease.
Topics: Activities of Daily Living; Aged; Angioplasty; Arterial Occlusive Diseases; Clinical Protocols; Exer | 1993 |
Prevention studies with pentoxifylline: new clinical projects.
Topics: Animals; Arterial Occlusive Diseases; Bone Marrow Transplantation; Humans; Pentoxifylline; Phosphodi | 1995 |
Optimal management of chronic leg ulcers in the elderly.
Topics: Administration, Oral; Aged; Aging; Arterial Occlusive Diseases; Aspirin; Bandages; Combined Modality | 1997 |
Pharmacologic management of peripheral vascular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Diseases; Cardiovascular Agents; Cycloo | 1998 |
A primary care approach to the patient with claudication.
Topics: Arterial Occlusive Diseases; Cilostazol; Exercise; Humans; Patient Education as Topic; Pentoxifyllin | 2000 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agent | 1979 |
Pentoxifylline -- a biomedical profile.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Erythrocy | 1979 |
Clinical considerations and treatment of diabetic angiopathy.
Topics: Adult; Arterial Occlusive Diseases; Coronary Disease; Diabetic Angiopathies; Humans; Intermittent Cl | 1979 |
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
[Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Topics: Arterial Occlusive Diseases; Chronic Disease; Combined Modality Therapy; Hemodilution; Humans; Pento | 1986 |
30 trials available for pentoxifylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
Topics: Adult; Aged; Analysis of Variance; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Bli | 1981 |
Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Me | 1982 |
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; E | 1982 |
Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
Topics: Alprostadil; Arterial Occlusive Diseases; Combined Modality Therapy; Exercise Therapy; Female; Follo | 1994 |
Treatment of vasculogenic sexual dysfunction with pentoxifylline.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Pressure; Brachial Artery; Coitus; Comorb | 1993 |
Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Biomarkers; Cell Adhesion; Chemotaxis, Leukocy | 1995 |
Controlled clinical trial on the efficacy and safety of oral sulodexide in patients with peripheral occlusive arterial disease.
Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Drug Monitoring; Female; Glycosaminoglycans | 1997 |
Therapeutic effects of Vascupump treatment patients with Fontaine Stage II B arteriopathy.
Topics: Arterial Occlusive Diseases; Exercise Test; Humans; Intermittent Claudication; Massage; Pentoxifylli | 2001 |
[On the treatment of acute arterial circulatory disturbances of the retina and optic nerve (author's transl)].
Topics: Acute Disease; Aged; Anticoagulants; Arterial Occlusive Diseases; Bencyclane; Clinical Trials as Top | 1977 |
[Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; F | 1977 |
[Influence of vasoactive substances on blood sugar and serum insulin in normal and diabetic carbohydrate metabolism (author's transl)].
Topics: Actihaemyl; Arterial Occlusive Diseases; Bencyclane; Blood Glucose; Diabetes Mellitus; Female; Gluco | 1977 |
[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood; Clinical Trials as Topic; Female; Gait; Hemodynamic | 1977 |
[Treatment of arterial diseases with trental 400. Results of a double-blind study].
Topics: Arterial Occlusive Diseases; Double-Blind Method; Drug Evaluation; Humans; Intermittent Claudication | 1978 |
[Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinical | 1976 |
[A therapeutic comparison between hemodilution and pentoxifylline in arterial obstructive disease. An objective assessment by quantitative Doppler sonography].
Topics: Aged; Arm; Arterial Occlusive Diseases; Female; Hemodilution; Hemodynamics; Humans; Leg; Male; Middl | 1992 |
[Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Female; Hemodynamics; Humans; Infusions, Intravenous | 1991 |
[Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
Topics: Alprostadil; Arterial Occlusive Diseases; Combined Modality Therapy; Exercise Therapy; Female; Human | 1991 |
Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Double-Blind Met | 1989 |
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Electr | 1989 |
Intravenous oxypentifylline in critical limb ischaemia.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesia; Arterial Occlusive Diseases; Blood | 1989 |
Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Double-Blind Method; Female; Humans; Intermittent | 1989 |
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Chronic Disease; Follow-Up Studies; Humans; Multicen | 1989 |
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
[Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Humans; Infusions, Intra | 1987 |
[Training by walking and drug therapy of peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind | 1987 |
Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Topics: Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Exercise Test; Humans; Inter | 1987 |
[Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality | 1987 |
Blood flow properties and walking performance in chronic arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood; Blood Circulation; Blood Viscosity; Chronic Disease; Clini | 1985 |
Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Clinical Tria | 1985 |
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroer | 1985 |
66 other studies available for pentoxifylline and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Hand angiography in connective tissue disease.
Topics: Adult; Angiography; Arterial Occlusive Diseases; Contrast Media; Female; Hand; Humans; Mixed Connect | 2012 |
[New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Exercise Test; Humans; Intermittent Claudicat | 2002 |
[Peripheral arterial occlusive disease (PAVK)].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Arteries; Cilostazol; Evidence-Based Medicine; Ex | 2003 |
[Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities].
Topics: Acute Disease; Adolescent; Adult; Aged; Arm; Arterial Occlusive Diseases; Aspirin; Dextrans; Female; | 1980 |
The role of fibrinolysis in the therapy of peripheral vascular disease.
Topics: Alprostadil; Animals; Arterial Occlusive Diseases; Drug Synergism; Fibrinolysin; Fibrinolysis; Macac | 1984 |
[Capillary permeability in cardiovascular diseases based on radioindication data].
Topics: Adult; Arterial Occlusive Diseases; Capillary Permeability; Cardiovascular Diseases; Coronary Diseas | 1984 |
Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
Topics: Adenosine Triphosphate; Age Factors; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Erythrocyt | 1984 |
Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
Topics: Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Blood Viscosity; Drug Therapy, Combination; F | 1984 |
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Topics: Alprostadil; Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Platelets; Drug Sy | 1984 |
[Effect of pentoxifylline on the dissociation curve of oxyhemoglobin].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Male; Oxygen Consumption; Oxyhemoglobins; Pentoxi | 1983 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifyllin | 1983 |
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic | 1981 |
Specific methods to determine hemorheological parameters.
Topics: Arterial Occlusive Diseases; Brain Ischemia; Erythrocyte Aggregation; Erythrocytes; Hematologic Test | 1981 |
Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
Topics: Adenosine Triphosphate; Arterial Occlusive Diseases; Blood Coagulation Disorders; Chronic Disease; E | 1981 |
The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Elasticity; Female; Hematocrit; Humans; Injectio | 1981 |
[Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Heart Rate; Humans; Muscles; Pentoxifylline; Theobromi | 1981 |
[Hemorrheologic aspects in relation to the physiopathology and clinical aspects of peripheral occlusive arteriopathy].
Topics: Adenosine Triphosphate; Arm; Arterial Occlusive Diseases; Blood Circulation; Blood Viscosity; Erythr | 1981 |
[Clinical pharmacology of vasoactive substances: study on pentoxifylline].
Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; M | 1981 |
The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience.
Topics: Arterial Occlusive Diseases; Humans; Optic Nerve Diseases; Pentoxifylline; Retinal Artery; Retinal D | 1981 |
[Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle | 1981 |
[Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Humans; Leg; Male; Middle Aged; Pentoxif | 1981 |
[Arterial occlusive disease: reducing blood viscosity through drugs].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocyte Membrane; Humans; Membrane Fluidity; Pento | 1981 |
[Worsening of arterial occlusive diseases by pentoxifylline?].
Topics: Arterial Occlusive Diseases; Humans; Pentoxifylline; Theobromine | 1980 |
Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.
Topics: Adult; Antifibrinolytic Agents; Antithrombin III; Arterial Occlusive Diseases; Blood Flow Velocity; | 1980 |
[Drug therapy of arterial diseases. A study with Trental 400].
Topics: Adult; Arterial Occlusive Diseases; Blood Pressure; Drug Evaluation; Drug Tolerance; Humans; Male; M | 1980 |
[Use of transcatheter intra-arterial infusion of drug mixtures in the combined treatment of patients with obliterating vascular diseases in the terminal stage of limb ischemia].
Topics: Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Arterial Occlusive Diseases; Ascorbic Acid | 1994 |
Treating peripheral arterial occlusive disease: pentoxifylline vs exercise.
Topics: Aged; Antigens, CD; Arterial Occlusive Diseases; CD11 Antigens; CD18 Antigens; Cell Adhesion Molecul | 1994 |
[Treatment of trophic ulcers of the lower extremities with Trental-400].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Chronic Disease; Drug Evaluation; Human | 1996 |
Medical cost savings from pentoxifylline therapy in chronic occlusive arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Cost Savings; Health Care Costs; Humans; Middle Aged; Mode | 1994 |
[Prevention of early thrombotic complications after reconstructive operations in occlusions of the aorto-iliac segment].
Topics: Adult; Aged; Anticoagulants; Aorta, Abdominal; Aortic Diseases; Arterial Occlusive Diseases; Aspirin | 2000 |
Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits.
Topics: Animals; Antioxidants; Aortic Diseases; Arterial Occlusive Diseases; Biomarkers; Cytokines; Disease | 2002 |
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Humans; Microcirculation; Muscles; Oxyge | 1979 |
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Blood Platelets; Chronic Disease; Femal | 1979 |
[Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Evaluation Studies as Topic; Female; Germany, We | 1979 |
[Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Circulation; Drug Evaluation; Embolism; Hemodynami | 1979 |
Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Erythrocytes; Humans; Middle Aged; Pentoxifylline; Regiona | 1979 |
[Therapy of arterial vascular occlusions of retinal and optic nerve (author's transl)].
Topics: Administration, Oral; Arterial Occlusive Diseases; Humans; Optic Nerve; Pentoxifylline; Retinal Arte | 1979 |
[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
Topics: Arterial Occlusive Diseases; Exercise Therapy; Femoral Artery; Humans; Hyperemia; Intermittent Claud | 1979 |
[Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Topics: Arterial Occlusive Diseases; Bencyclane; Blood Proteins; Blood Viscosity; Cycloheptanes; Humans; Mat | 1978 |
[Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Topics: Aged; Arm; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Drug Evaluation; Femal | 1978 |
The effect of pentoxifylline on the flow properties of human blood.
Topics: Arterial Occlusive Diseases; Erythrocyte Count; Erythrocytes; Humans; In Vitro Techniques; Osmolar C | 1978 |
[The treatment of chronic arterial bloodcirculation interference (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Cholesterol; Drug Evaluation; Female; Humans; Leg; Leg Ulc | 1978 |
[5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Eye Diseases; | 1977 |
Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
Topics: Arterial Occlusive Diseases; Bencyclane; Blood Viscosity; Chronic Disease; Cycloheptanes; Humans; Pe | 1977 |
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Topics: Adenosine Triphosphate; Ancrod; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; E | 1976 |
[20 years pentoxifylline: a part of recent angiology history].
Topics: Arterial Occlusive Diseases; Germany; History, 20th Century; Humans; Intermittent Claudication; Pent | 1992 |
Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cohort Studies; Confidence Intervals; Costs an | 1992 |
Pentoxifylline in arterial disease of the legs.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Fibrinolytic Agents; Humans | 1991 |
Pentoxifylline in the treatment of vascular impotence--case reports.
Topics: Aged; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; Intermittent Claudication; Leg; Mal | 1991 |
[Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leg; Mal | 1990 |
Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Humans; Male; Midd | 1990 |
[Increasing the effectiveness of hyperbaric oxygenation in the treatment of patients with stage IV arterial occlusive diseases of the lower limbs].
Topics: Arterial Occlusive Diseases; Combined Modality Therapy; Dextrans; Follow-Up Studies; Humans; Hyperba | 1985 |
Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Exercise Test; Female; Hemodynamics; Human | 1989 |
Trends in revascularization of the lower extremity.
Topics: Angioplasty, Balloon; Aorta, Abdominal; Arterial Occlusive Diseases; Femoral Artery; Humans; Iliac A | 1986 |
Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cyclic AMP; Drug Resist | 1987 |
[Intra-arterial therapy of arterial occlusive diseases of the extremities].
Topics: Actihaemyl; Adenosine Triphosphate; Anti-Bacterial Agents; Arterial Occlusive Diseases; Drug Therapy | 1987 |
[Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Topics: Arterial Occlusive Diseases; Blood Cell Count; Blood Viscosity; Exercise Test; Female; Hematocrit; H | 1987 |
Adenine nucleotides in erythrocytes from patients with peripheral vascular disease and the effects of oxpentifylline.
Topics: Adenine Nucleotides; Adult; Aged; Arterial Occlusive Diseases; Cells, Cultured; Erythrocyte Deformab | 1987 |
Failure of pentoxifylline for end-stage peripheral vascular disease.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Humans; Intermittent Claudic | 1987 |
[Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Viscosity; Drug Therapy, Combination; Female; Hum | 1987 |
Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; | 1986 |
Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease.
Topics: Arterial Occlusive Diseases; Blood Pressure; Female; Femoral Artery; Humans; Infusions, Parenteral; | 1986 |
Drug therapy for peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Humans; Pentoxifylline; Theobro | 1986 |
Altered low density lipoproteins in peripheral vascular disease patients.
Topics: Aged; Arterial Occlusive Diseases; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies | 1986 |
Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Topics: Aged; Arterial Occlusive Diseases; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg; | 1985 |
Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mell | 1985 |